MicroVision, Inc. Appoints New CFO Christine Chambers

What Happened

• MicroVision, Inc. announced on August 7, 2026 that Christine Chambers (age 49) was appointed Chief Financial Officer and principal financial and accounting officer, effective August 27, 2026. The appointment and related compensation were approved by the Compensation Committee.
• Ms. Chambers most recently served as CFO of Fusemachines (July 2025–Aug 2026) and previously held senior finance roles at PetMed Express, RealNetworks and Rosetta Stone; she holds an MBA from the University of Washington and a bachelor’s in finance from Loughborough University.

Key Details

• Base salary: $425,000 per year.
• Annual incentive: target equal to 65% of base salary, payable in cash or vested RSUs.
• Equity awards: one-time new-hire RSU award valued at $1,000,000 vesting over 4 years; annual long-term RSU opportunity valued at $800,000 vesting in three equal annual installments.
• Severance/benefits: eligible for the Company’s Key Executive Severance and Change in Control Plan as a Tier 2 Executive (effective three months after start) and standard employee benefits.
• Transition: Stephen Hrynewich will cease serving as Interim CFO effective August 27, 2026 and will continue in a senior finance role; the company said the transition was not due to any disagreement.

Why It Matters

• A permanent CFO appointment affects MicroVision’s financial leadership, reporting and investor communications; the compensation package emphasizes equity-based incentives tying Ms. Chambers’ pay to company performance and retention.
• The orderly transition from the interim CFO and the absence of any reported disagreement reduce uncertainty about near-term finance leadership continuity for investors.